CCMP CAPITAL
CCMP CAPITAL is a Series C+ and buyout fund in the US and Europe writing $100M–$500M checks into Consumer, Healthcare and industrial.
- Stages
- Series C+, buyout
- Sectors
- Consumer, Healthcare, industrial
- Check size
- $100M–$500M
- Invests in
- US-wide, Europe
- Founded
- 1984
- Website
- ccmpcapital.com
Thesis
CCMP Capital is a private equity firm specializing in leveraged buyouts and growth capital transactions, with a strategic focus on North America and Europe. They target established businesses in the consumer, industrial, and healthcare sectors, aiming to create value through operational enhancements and strategic guidance. While primarily seeking control investments, they may consider minority stakes with significant influence. CCMP Growth Advisors, launched in 2023, focuses on control growth buyouts of high-growth, middle-market companies in the consumer and industrial sectors, with check sizes from $50M-$150M. The firm's predecessor, JP Morgan Partners, had invested approximately $12 billion. CCMP Capital Investors II closed at $3.4 billion in 2007, CCMP Capital Investors III closed at $3.6 billion in 2014, and CCMP IV closed at over $500 million in 2024. Typical equity checks for buyouts and growth equity range from $100M-$500M. The firm was founded in 1984 and evolved from Chemical Bank's private equity arm. They have offices in New York, Houston, and London.
Common questions
Does CCMP CAPITAL invest at the Series C+ stage?
Yes. CCMP CAPITAL lists Series C+ and buyout among the stages it invests in.
What check size does CCMP CAPITAL write?
CCMP CAPITAL writes $100M–$500M checks.
Where does CCMP CAPITAL invest?
CCMP CAPITAL invests in the US and Europe.